Skip to content
Open access

Mechanistic Elucidation of Yiqi Yangyin Qingre Decoction in Diabetic Nephropathy Therapy via Network Pharmacology and In Vivo Validation

Jan 2026 · Journal of Diabetes Research · Vol 2026 · 0 citations · 27 references
Medicine

TL;DR

YQYYQR exerts a protective effect against DN progression by targeting core genes including GSK3β, regulating the GSK3β‐TFEB axis to restore autophagic flux via the autophagy‐lysosomal pathway, and inhibiting NLRP3‐mediated pyroptosis to mitigate excessive renal inflammation.

Abstract

Background Diabetic nephropathy (DN) is a serious microvascular complication of diabetes that urgently requires effective treatments with low toxicity. The traditional Chinese medicine formula Yiqi Yangyin Qingre decoction (YQYYQR) has demonstrated potential in alleviating DN, yet its pharmacological mechanism remains unclear. Methods UPLC‐MS/MS combined with network pharmacology was utilized to qualitatively analyze YQYYQR′s bioactive components and predict therapeutic targets. Integrating public databases and GEO‐derived DN‐related genes, core targets were identified via intersection and subjected to pathway enrichment. Molecular docking validated key component–core target interactions, with in vivo DN mouse experiments and transcriptome sequencing performed for verification. Results This study identified 376 bioactive components from YQYYQR, corresponding to 1284 potential therapeutic targets. Cross‐analysis between these targets and DN‐related genes yielded 57 overlapping targets, among which GSK3β and NFKB1 were screened as core hub genes. Network pharmacology and transcriptomic pathway enrichment analyses indicated that the mechanism of YQYYQR in intervening DN involves biological processes such as autophagy and inflammatory response. In vivo, YQYYQR significantly improved mouse proteinuria and renal function and alleviated pathological kidney damage. Mechanistically, YQYYQR enhanced the inhibitory phosphorylation of GSK3β at Ser9, thereby facilitating TFEB nuclear translocation and activating the autophagy‐lysosomal pathway. Simultaneously, it suppresses the NLRP3/ASC/caspase‐1/GSDMD‐N–mediated pyroptosis pathway, ultimately reducing renal inflammation. Conclusion YQYYQR exerts a protective effect against DN progression by targeting core genes including GSK3β, regulating the GSK3β‐TFEB axis to restore autophagic flux via the autophagy‐lysosomal pathway, and inhibiting NLRP3‐mediated pyroptosis to mitigate excessive renal inflammation.

Read PDF

Similar papers

Jul 2026

Integrated Network Pharmacology and Experimental Study: Bioactive Compounds and Mechanisms of XuanTong BuLuo Decoction in Treating Diabetic Cardiomyopathy.

It is demonstrated that XTBLD exerts cardioprotective effects against DCM via regulating its key active components, core targets (CDKN1A, IGFBP3), and related signaling pathways, providing a scientific basis for XTBLD's clinical application in DCM management.

Min Wang, Kaijie Xie, Hao Liu et al. · 0 citations
Open access Aug 2026

Exploring the anti-inflammatory targets of Gui-qi-yi-shen granules in diabetic nephropathy: insights from network pharmacology, transcriptomics, and experimental verification

Clinical and animal experiments have shown that Gui-qi-yi-shen (GQYS) granules, a traditional Chinese medicine formula, exhibited considerable therapeutic efficacy in the treatment of diabetic nephropathy (DN). However, the underlying pharmacological mechanisms remain unknown. To address this, we investigated the poten...

Jia-Wei Cao, Meng-Dan Lu, Peng Bi et al. · 0 citations
Jul 2026

Network Pharmacology, Machine Learning, and In Vivo Validation of Danzhi Jiangtang Capsule in Diabetic Nephropathy.

Although Danzhi Jiangtang Capsule (DJC) is a traditional Chinese herbal preparation used clinically for diabetes, how it may protect the kidney during diabetic nephropathy (DN) has not been fully clarified. This investigation was designed to explore potential mechanisms by which DJC affects DN, with a focus on the NLR...

Zi-Qiang Li, Ying Yuan, Yueyue Zhao et al. · 0 citations
Open access Jan 2026

Integrating Network Pharmacology and In Vitro Experiments to Elucidate the Antiatherosclerotic Mechanisms of Qingxin Tongmai Yin

It is suggested that QXTMY may exert protective effects against AS, potentially via suppression of the AGE‐RAGE‐mediated inflammatory axis, however, in vivo validation is still required to support these preliminary conclusions.

Yang-Fan Huang, Zhengshu Xia, Zhi-Yong Yu et al. · 0 citations
Aug 2026

Elucidating the Therapeutic Mechanism of Puhuaiyin in Rosacea: An Integrated Study Based on Network Pharmacology, Bioinformatics, Molecular Docking, and Molecular Dynamics Simulations.

BACKGROUND Rosacea is a chronic inflammatory skin disorder with limited therapeutic options. Puhuaiyin (PHY), a traditional Chinese medicinal formula, shows clinical efficacy, but its multi-component mechanisms remain unclear. METHODS Chemical constituents of PHY were identified by UPLC-Q-TOF-MS. Network pharmacology...

Dan Sun, Na-Na Yang, Yi-Ding Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.